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INTRODUCTION
Canine babesiosis, an important tick-borne 
infectious disease of dogs, has been described as 
an emerging veterinary problem worldwide 
(Duh et al., 2004; Irwin 2009). The disease is 
caused by an intraerythrocytic protozoan 
parasite of the genus Babesia with two main 
species; Babesia canis and Babesia gibsoni as the 
major culprits, even though B. canis has been 
shown to be more prevalent (Taboada and 
Merchant, 1991). The increasing number of 
canine Babesia  species ,  geographical  
distribution, varying tick vectors and modes of 
transmission often result in motley of pathogenic 
and clinical presentations (Ayoob et al., 2010); 
however, the general signs observed may range 
from a hyperacute shock-associated haemolytic 
crisis to an inapparent subclinical infection. Most 
dogs present with the acute form of the disease 
with clinical signs as fever, depression, anorexia, 
mucous membrane pallor, lymphadenopathy, 
splenomegally and general malaise (Birkenheuer 
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et al., 1999).
Advances in molecular biology has led to 
improvements in the diagnosis of the disease and  
also the nature of the parasites, the outcome of 
which is the discovery of new canine Babesia 
species and the inclusion of some Theileria 
species alongside the known Babesia species as 
being responsible for canine piroplasms.  
TRANSMISSION, BIOLOGY 
AND MOLECULAR SPECIATION  
Transmission of Babesia parasite to the canine 
host is by the bite of specific ixodid tick vectors of 
the genus Rhipicephalus (Rhipicephalus 
sanguineus), Haemaphysalis (Haemaphysalis 
leachi, H. bispinosa and H. longicornis) and 
Dermacentor (Dermacentor reticulatus). Thus the 
specie of Babesia prevalent in a particular area is 
influenced by the presence of the specific tick 
vector in that geographical area (Birkenheuer et 
al., 1999; Matjila et al., 2004). 
Birkenheuer et al. (1999), Miyama et al. (2005) 
and Jefferies et al. (2007a) have suggested a 
direct dog to dog transmission of B. gibsoni. They 
suspect that the parasite is transmitted through 
blood and saliva when an infected dog with oral 
abrasions bites a naïve dog during fights. This 
bite-blood-saliva transmitted B. gibsoni infection 
has been associated with breeds of dogs 
renowned for aggression, such as the American 
Staffordshire/Pit Bull terriers in the USA and the 
Tosa breed in Japan. Transplacental  
transmission has been reported in puppies as 
young as 3 days old while experimental infection 
has led to stillbirths or death of puppies 6 weeks 
post partum (Meinkoth et al., 2002; Fukumoto et 
al., 2005; Jefferies et al., 2007a). 
Babesia parasites have traditionally been 
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differentiated phenotypically based on their 
appearance in stained blood smears particularly 
using the size of their piroplasms as either small 
(B. gibsoni: 1µm ×3.2µm) or large (B. canis: 3µm 
×5µm) (Passos et  al., 2005).
Babesia canis trophozoites are large bilobed 
piriform organisms of 4-5µm in length and 2-
4µm in diameter and appear as round, oval or 
ringed-shaped inside erythrocytes (Lewis et al., 
1996). Three subspecies of Babesia canis have 
been recognized namely; Babesia canis canis, 
Babesia canis rossi and Babesia canis vogeli, all of 
which are identical morphologically but differ in 
geographical distribution, antigenic properties, 
virulence and tick vector (Uilenberg et al., 1989; 
Caccio et al., 2002). However, two new large 
Babesia species which have not been given a 
taxonomic status have been reported in North 
America by Birkenheuer et al. (2004), and 
another in Brazil that seems to be different from 
Babesia  and Theileria  because of its 
intraendothelial stage (Loretti and Barros, 
2005). Also Baneth et al. (2004) are proposing 
new Babesia canis subspecie (Babesia canis 
presentii) which infects cats. This proposed 
subspecie shows a high molecular similarity of 
18S RNA genes with B. canis but is quite smaller 
in size. The distinct characteristics of each of 
these subspecies in terms of their geographical 
distribution, virulence, vector, pathogenicity, 
and antigenic properties have informed the 
decision of several authors to advocate for 
separate taxa for them (Schetters et al., 1997; 
Zahler et al., 1998; Baneth et al., 2004).
Babesia gibsoni which measures about 1-3.2µm 
and appears singly in erythrocytes initially was 
the only small piroplasm of dog identified. 
However, recent advances in molecular 
techniques have revealed that at least three 
morphologically similar but genetically distinct 
small Babesia parasites of dogs exist, and these 
include; Babesia gibsoni measuring 1-3.2µm and 
appears as either piriform or ring form, Babesia 
conradae which measures 1-2.5µm, and appears 
as ring, piriform, tetrad, amoeboid or 
anaplasmoid forms at the intraerythrocytic 
merozoite stage, with an apical complex and 
rhoptries under transmission electron 
microscope and Theileria (Babesia microti-like) 
annae which has a tetrad form at the merozoite 
stage, an apical complex and an exoerythrocytic 
stage (Thomford et al., 1993; Kjemtrup et al., 
2000; Goethert et al., 2003; Kjemtrup et al., 
2006; Matjila  et al., 2007). Note that under light 
microscopy the intraerythrocytic stage of Babesia 
spp. is indistinguishable from Theileria spp. and 
can only be seperated on the basis of certain life-
cycle stages and transovarial passage within the 
tick vector (Uilenberg, 2006). Other theileria 
species that have been recorded in dogs using 
18S rRNA gene includes Theileria equi and 
Theileria annulata (Criado-Fornelio et al., 
2003b). In essence, the previous notion of 
Babesia spp being solely responsible for canine 
piroplasmosis is no longer tenable especially 
with the advent of molecular techniques, 
sequencing and phylogenetic analysis. Current 
publications on the use of these  methods in the 
analysis of the small sub-unit ribosomal RNA 
(ssrRNA) of canine piroplasms shows that they 
belong to three clades  ; 'true' Babesia sp. (B. 
canis and B. gibsoni), B. microti clade (Theileria 
annae) and the Theileria-like group (B. 
conradae). These observations have introduced a 
major change in the approach to the 
epidemiology of babesiosis in dogs. Also, the 
recent identification of unusual piroplasms 
(Theileria (Babesia) equi, Theileria annae, 
Theileria annulata, Babesia caballi) other than 
Babesia canis sp and Babesia gibsoni in dogs is 
worrisome and may be responsible for the non-
responsive treatment of canine babesiosis cases 
in the clinics using the standard dosage of 
imidocarb dipropionate at 3 mg/kg (Criado-
Fornelio et al., 2003, Criado et al., 2006, Fritz, 
2010).
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EPIDEMIOLOGY
Tick vectors and distribution 
The distribution of canine Babesia parasites is 
world wide and is dependent on the presence of 
the specific tick vector responsible for their 
transmission, such that the Babesia canis vogeli 
which is transmitted by Rhipicephalus sanguineus 
is seen in North Africa, South America, Southern 
and Eastern Africa, and European countries 
(Duh et  al., 2004; Matjila et al., 2004; Oyamada 
et al., 2005; Eiras et al., 2008; M'ghirbi and 
Bouattour, 2008); Babesia canis rossi transmitted 
by Haemaphysalis elliptica (Apanaskevich et al., 
2007) is seen in South Africa and Sudan 
(Oyamada et al., 2005; Matjila et al., 2008a; 
Matjila et al., 2008b), whereas Babesia canis 
canis transmitted by Dermacentor reticulatus is 
distributed mainly in Europe (Caccio et al., 2002; 
Duh et al., 2004; Solano-Gallego et al., 2008). 
Dermacentor reticulatus is an exophilic and 
ditropic tick found mainly in forests, but adapted 
to suburban habitats and is the major vector 
species of canine babesiosis in France 
(Bourdoiseau, 2006). 
The small Babesia (Babesia gibsoni, Babesia 
conradae and Babesia (Theileria) annae) which 
has three genetically distinct entities are found 
mainly in Asia (Farwell et al., 1982; Fukumoto et 
al., 2001; Song et al., 2004; Miyama et al., 2005; 
Matjila et al., 2007), North America (Conrad et 
al., 1991; Kjemtrup et al., 2006a; Kjemtrup et al., 
2006b) and Europe (Kjemtrup, 2000; Camacho-
Garcia, 2006). Babesia conradae has been shown 
to be closely related to piroplasm isolates from 
wildlife and humans and distributed around the 
California area of USA while Babesia (Theileria) 
annae is similar to Babesia microti and Theileria 
equi and occurs mainly in Spain (Kjemtrup et al., 
2006; Camacho-Garcia, 2006). The vector for 
this emergent canine infection has not been 
described, although Ixodes hexagonus is 
suspected based on their presence upon dogs in 
North-West of Spain and the relative absence of 
other ticks (Dixit et al., 2010). What the above 
information means is that the detection of a 
small piroplasm in the erythrocytes of dogs is not 
indicative of Babesia gibsoni, for the simple 
reason that the small piroplasms share similar 
morphology. Thus, B. gibsoni  cannot 
unequivocally be differentiated from B. equi or B. 
microti based on size, shape or location in the 
erythrocytes (Conrad et al., 1992; Zahler et al., 
2000).
 
Table I: Summary of Piroplasms identified in  dogs from  different  areas of the world
 
Species Size Areas reported Tick vector References
Large Babesia spp 
B. canis  canis Europe and Asia                Dermacentor reticulatus      ? ines ., 2010et al  
Rhipicephalus sanguienus    Adaszek and Winiarczyk,  2008
Nigeria   ,,                ,,     Kamani et al., 2010  
B. canis  rossi                      South Africa             
 
Nigeria   unknown     Kamani et al., 2010  
B. canis  vogeli Africa, Asia,Australia,      Rhipicephalus sanguineus    M’ghirbi and Bouattour,  2008 
Europe, South America                                               
New Large Babesia spp.  North Carolina                     
         
 Babesia caballi            2µm–4 µm        France, Croatia   Unknown                                 
Fritz 2010
  
Small Babesia spp 
Babesia gibsoni             Africa, Asia,Australia,         Haemophysalis leachi,          Varshney   et al ., 2008    
   Europe, South America  Rhipicephalus sanguineus     Hartelt  et al., 2007  
  and USA.   
Babesia conradae                        Unknown  
  
Theileria (Babesia microti) Northwestern Spain                 Ixodes hexagonus?              
 2000annae  
       
      
 
Theileria (Babesia) equi         Spain                  
  
Unnamed Theileria sp                
  





Unknown        
               Unknown 
Haemaphysalis elliptica          Matjila et al.., 2009  
3 µm- 5 µm 
Beck et al., 2009 
2 µm–5 µm         
Lehtinen et al., 2008 
Birke et al., 2004nheuer 
and USA. 
Beck et al., 2009 
3 µm -5 µm                
3 µm-5 µm    
Unknown     
(Coco)
1 µm-3.2 µm
 1 µm-2.5 µm
California (USA) 1 µm- 2.5 µm     
1 µm-2.5 µm         
 
Kjemtrup et al., 2006                       ., 
Zahler et al., 2000
Camacho et al., 2003
 
 
                          Criado et al 2006.,
Mehlhorn and Schein, 1998        
 Criab - et al., 2003 a,bFornelio 
  Garcia 2006 
 
 Matjila et al   2008c.,South Afric
 Spain
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Ticks responsible for the transmission of small 
piroplasms in dogs are mainly Rhipicephalus 
sanguineus, an endophilic and monotropic tick 
adapted to premises, habitations, kennels and all 
biotopes in which man and dogs cohabit 
(Higuchi et al., 1995; Inokuma et al., 1998; 
Bourddoiseau, 2006), Haemaphysalis bispinosa 
(Grooves and Yap, 1968) and Haemaphysalis 
longicornis (Higuchi et al., 1991)(Table I). 
Canine piroplasmosis is a disease of young dogs 
even as young as 3weeks (Harvey et al., 1988), 
however older dogs coming from a Babesia-free 
zone can develop the disease on contact with an 
infected tick during a brief visit in an endemic 
zone, with the highest peak of the disease 
coinciding with the period most favourable for 
the tick vector activity which is usually at the 
beginning of the rains in tropical Africa and 
autumn/spr ing in  temperate  Europe 
(Bourdoiseau, 2006). 
Breed Susceptibility 
Although breed susceptibility and specificity has 
not been established for canine babesia 
infection, several authors have associated 
certain Babesia species with some dog breeds as 
espoused by Breitschwerdt et al. (1983) ; 
Yamane et al. (1994) and Birkenheuer et al. 
(2005) who reported a 50-55% seropositivity of 
B. canis vogeli infection in Greyhounds breeds 
whereas susceptibility rate for B. gibsoni- 
seropositive dogs among the American 
Staffordshire and Pit Bull Terriers breeds was put 
at 15-93% (Macintire et al., 2002; Birkenheuer et 
al., 2003b; Birkenheuer et al., 2005). 
DIAGNOSIS 
Babesia infections are traditionally diagnosed 
based on the detection of the parasites in thin 
blood smears stained with Giemsa, Romanowsky 
and field stains under a microscope. The blood 
smears prepared from capillary blood and buffy 
coat readily reveals the parasites since the 
parasitized erythrocytes tend to sludge in the 
capillaries and also preferentially parasitize the 
reticulocytes over the mature red blood cell 
(Mattia et al., 1993; Bohm et al., 2005). 
Identification of the parasites relies on the 
morphology of the intraerythrocytic forms using 
their size; however, this method is affected by its 
limited sensitivity and the subjectivity of the 
observer especially during asymptomatic and 
chronic infections when the parasitaemia is low 
and usually undetected by microscopy (Song et. 
al., 2004; Miyama et al., 2005). 
Fukata et al. (1996) and Yamasaki et al. (2008) 
have developed a flow cytometry to diagnose 
and evaluate the level of B. gibsoni parasitaemia 
in vivo and in vitro using a fluorescent nucleic 
acid stain SYTO16 which has been shown to be 
rapid and reliable. Other serological tests that 
have been used for the diagnosis of canine 
babesiosis are indirect fluorescent antibody 
technique (IFAT) and enzyme linked 
immunosorbent assay (ELISA) technique 
(Yamane et al., 1993; Fukumoto et al., 2004); 
however, these serological tests are known to 
show cross-reaction between different species of 
Babesia and do not differentiate acute from 
chronic infection thus making them non-specific 
(Yamane et al., 1994; Irwin, 2007).  Cross-
antigenicity seen in the B. canis subspecies is 
thought to be responsible for vaccine failures in 
the field as observed by Uilenberg et al. (1989) 
and Schetters et al. (1995), thus the possibility of 
developing potent vaccines against canine 
babesiosis will be dependent on the proper 
differentiation of the different subspecies.
Polymerase chain reaction (PCR) with its several 
variations as a diagnostic tool for Babesia 
parasites has been evaluated and found suitable 
because of its sensitivity and  specificity which is 
estimated to approach 100% (Jefferies et al., 
2007b), and its ability to detect past, 
asymptomatic and current infect ions 
(Birkenheuer et al., 2003a; Song et al., 2004; 
Miyama et al., 2005). This method lays emphasis 
on the amplification of the babesia DNA instead 
of the anti-babesial antibodies, thus making it a 
very reliable diagnostic tool in acute, peracute, 
and chronic infections most especially in 
immunocompromised and young dogs 
(Fukumoto et al., 2001). It has also been found 
quite useful in epidemiological studies for the 
identification of new subspecies and for the 
differentiation of close and genetically distant 
Babesia species (Ano et al., 2001; Birkenheuer et 
al., 2003a). 
Recent advances in molecular techniques have 
seen an avalanche of methods used to diagnose 
these parasites. Some of these methods which 
usually incorporate PCR in their procedures 
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include; Reverse line Blot hybridization (Matjila 
et al., 2004; Matjila et al., 2008) and Restriction 
fragment length polymorphism (Conrad et al., 
1992; Carret et al., 1999; Solano-Gallego et al., 
2008) amongst others. To achieve optimal 
diagnostic accuracy, Irwin (2009) advocates a 
combination of IFAT and PCR even though he 
was silent on the cost effectiveness of such test 
especially in developing countries. For 
subspecies differentiation and phylogenetic 
analysis, sequencing of the full-length small 
subunit ribosomal RNA (ssrRNA) is the method 
of choice since there in no ambiguity in the 
results generated from using it (Caccio et al., 
2002; Eiras et al., 2008).
CLINICOPATHOLOGICAL FINDINGS 
The clinical and pathological presentation of 
canine babesiosis varies and is dependent on the 
species/subspecies responsible for the infection; 
however, the classical presentations often 
include: Thrombocytopenia, febrile syndrome 
(Fever, anorexia, depression, dehydration) and 
haemolytic syndrome (anaemia, bilirubinuria, 
haemolysis) in acute cases while the chronic 
form corresponds to prolonged convalescence 
characterized by depression (Bourdoiseau, 
2006; Solano-Gallego et al., 2008). In terms of 
severity of infections associated with the 
subspecies of Babesia canis, evidence shows that 
Babesia canis rossi is the most virulent  with 
haemolytic and inflammatory responses (Reyers 
et al., 1998), Babesia canis canis shows a 
transient parasitaemia (<1%) associated with 
congestion of internal organs (Schetters et al., 
1997), where as Babesia canis vogeli lead to a 
relatively mild infection, often without clinical 
signs or where present may not be homogenous 
(Caccio et al., 2002; Solano-Gallego et al., 2008). 
Infections due to Babesia gibsoni are usually 
associated with splenomegally, hepatomegally, 
haemolytic anaemia and severe thrombo-
cytopenia (Conrad et al., 1991; Matjila et al., 
2007). Clinical signs of Babesia conradae are 
similar to those of B. gibsoni, but B. conradae 
infection is more pathogenic with pronounced 
anaemia, higher parasitaemia and lympha-
denopathy (Kjemtrup and Conrad, 2006). 
Babesia (Theileria) annae infection is 
characterized by severe regenerative anaemia 
and thrombocytopenia, azotemia is seen in many 
cases, while the presence of hyaline and granular 
casts in the urine of infected dogs is suggestive of 
renal involvement in the disease (Camacho-
Garcia, 2006).
TREATMENT 
Drugs that have been used for the treatment of 
canine babesiosis (Atavaquone, azithromycin, 
diminazene aceturate, phenamidine isethionate, 
pentamidine, parvaquone, niridazone and 
trypan blue) are known to be unable to 
completely eliminate the parasites and the 
disease, but can only reduce the severity of the 
clinical signs and the mortality Birkenheuer et al. 
(1999). These drugs show varying degrees of 
success rates either alone or in combination in 
terms of eliminating the parasites or reducing 
the parasite load as was adduced by Birkenheuer 
et al. (1999) and Matjila et al., 2007. Although 
no known drug(s) has the capacity to treat 
infection due to Babesia canis, the report of 
Birkenheuer et al. (2004b) showed that a 
combination of azithromycin and atovaquone 
therapy is able to treat Babesia gibsoni infections 
in dogs successfully without infected 
erythrocytes being seen in capillary blood smear; 
also blood from dogs with this combination 
therapy was shown to be negative on PCR assay 
for about 4 months. This information seem more 
encouraging when compared to single therapy 
with atovaquone in which B. gibsoni parasite 
DNA were intermittently detected in the blood of 
experimentally infected dogs 33 days after the 
last treatment (Matsu et al., 2004), thus 
supporting the assertion by Choidioni et al. 
(1995) and Wittner et al. (1996) that recurrence 
of disease and decreased sensitivity to protozoa 
parasites (Plasmodium falciparum and Babesia 
microti) occurred following therapy with 
atovaquone alone. 
Although research has shown that treatment of 
canine babesiosis due to B. gibsoni with 
diminazene and or imidocarb is ineffective 
(Birkenheuer et al., 1999; Stageman et al., 
2003), it is imperative to state that Imidocarb has 
the capacity to stop the multiplication of the 
intraerythocytic parasites and also allow the 
persistence of several parasites in order to induce 
immunity and as such are desirable for the 
treatment of infection due to B. canis (Brandao et 
al., 2003; Bourdoiseau, 2006). 
Most if not all the babesiacidal drugs are toxic to 
the host and are used with the utmost caution. 
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Toxicity with these drugs is expressed in form of 
CNS disorders (diminazene); vomiting, colic and 
diarrhoea alongside hepatic, renal or vascular 
complications (imidocarb). Irrespective of the 
drug(s) used for the treatment of canine 
babesiosis, it is recommended that supportive 
therapy using intravenous fluids, corticosteroids 
and blood transfusion be used alongside.
PROPHYLAXIS 
This involves chemoprophylaxis in which 
acaricides (amitraz, fipronil, permethrin) are 
applied topically to reduce the tick burden on the 
animal before a high dose of drug (Imidocarb) is 
injected intramuscularly. This allows the residual 
effect of the drug to offer protection for about 4-6 
weeks and is especially useful in animals with a 
history that contraindicates vaccination 
(Uilenberg et al., 1981; Bourdoiseau, 2006); and 
vaccination which involves the subcutaneous 
injection of soluble parasite antigens (SPA) 
vaccines prepared from in vitro cultures of B. 
canis canis and B. canis rossi. Currently, vaccines 
® ®(Nobivac  and Pirodog ) containing soluble 
parasite antigens (SPA) from cultures of Babesia 
canis and Babesia rossi  have been developed and 
are commercially available in Europe to protect 
dogs against heterologous Babesia canis 
infection (Bourdoiseau, 2006; Schetters et al., 
2006).
Schetters et al. (2006) proved that this vaccine 
induces protective immunity against clinical 
babesiosis resulting from heterologous challenge 
from 3 weeks after booster vaccination onwards, 
and remains effective for about 6 months. The 
®administration of  SPA vaccines (Nobivac  and 
®Pirodog ) requires that the animal be in good 
health, at least 5 months old, not given to 
pregnant females and not administered 
concurrently with other vaccines apart from 
rabies and leptospirosis vaccines (Bourdoiseau, 
2006).
THE NIGERIAN PERSPECTIVE
Canine babesiosis is common in Nigerian dogs 
due to prevalence of the tick vector, 
Rhipencephalus sanguineus (Abdullahi et al., 
1990). Diagnosis is usually by microscopy which 
is based on morphological classification of the 
parasite either as large (Babesia canis) or small 
(Babesia gibsoni), relating to their size within the 
erythrocytes (Adeyanju and Aliu, 1982; Bobade 
et al., 1989). Serological diagnosis by Enzyme 
Link Immunosorbent assay (ELISA) is rarely 
conducted on clinical cases, while molecular 
studies are occasional (Sasaki et al., 2007; 
Kamani et al., 2010). The few molecular studies 
that were undertaken provided information on 
subspecies of Babesia canis present in Nigerian 
dogs. Sasaki et al., (2007) reported the presence 
of Babesia canis rossi and B canis vogelli in 2.0% 
and 0.3% Nigerian dogs respectively using 
nested PCR and sequence analysis.  Kamani et al. 
(2010) using specific PCR for Babesia spp. and 
DNA sequencing reported for the first time in an 
untraveled Nigerian dog the presence of Babesia 
canis canis on the African continent as a co-
infection with Babesia canis rossi, also a rare 
occurrence. Prevalence of the disease in Nigeria 
has ranged between 2% and 43.6% and has been 
reported in all the states of the federation 
(Dipeolu, 1975; Bodade et al., 1989; Amuta et 
al., 2010). 
DISCUSSION
Canine babesiosis, an important tick-borne 
infectious disease of dogs is regarded as an 
emerging veterinary problem worldwide. The 
disease in Nigeria has been recorded in several 
publications, however recent reports using 
molecular techniques shows the presence of all 
the three large Babesia subspecies (Babesia canis, 
Babesia vogeli and Babesia rossi) in the country 
(Sasaki et al., 2007; Kamani et al., 2010), an 
information that is of grave consequence to the 
animals and of importance to the veterinary 
practitioners considering the various clinical 
presentations of the species. Infact the clinical 
report of Babesia rossi, (the most virulent of the 
species) and Babesia canis is of note since their 
presence, endemicity, and proven tick vectors 
(Haemaphysallis elliptica and Dermacentor spp) 
are associated with Eastern and Southern Africa, 
and Europe (Uilenberg, 1989; Oyamada, 2005; 
Matjila, 2008b).
The reports of these Babesia species in the 
country may not be surprising in view of the 
unregulated importation of exotic breeds of dogs 
from South Africa, and other areas of the world 
that are endemic with several species of the large 
Babesia, Babesia gibsoni-like parasites and 
Theileria sp. This is because translocation of 
infected dogs from Babesia endemic areas to free 
areas has been implicated as a major factor in the 
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spread of the parasite (Conrad et al., 1991).
Nigeria does not consider canine babesiosis as a 
control disease and as such does not enforce the 
pre-import blood testing or the post-importation 
blood testing involving serological and 
molecular testing from dogs entering the 
country. The danger of the above laxity in 
enforcing surveillance and import control is the 
possible introduction of foriegn tick vectors and 
their associated parasites/diseases into the 
country.
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